Gaviscon and Sennosides drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate) and Sennosides (senna). Common drug interactions include angioedema among females and splenic infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Gaviscon and Sennosides. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

What is Sennosides?

Sennosides has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 8,247 Sennosides users. Check the latest studies of Sennosides.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

31 people who take Gaviscon and Sennosides together, and have interactions are studied.

Gaviscon and Sennosides drug interactions.

What are the common drug interactions of Gaviscon and Sennosides, by gender? *:

female:

Angioedema (rapid swelling of the dermis)
Anosmia (partial or complete loss of the sense of smell)
Anxiety
Arthralgia (joint pain)
Atrial tachycardia (rhythm disturbance that arises in the atria)
Back pain
Blindness
Blood glucose increased
Cardiospasm (heart spasm)
Carotid artery occlusion (artery blockage)

male:

Splenic infarction (tissue damage of spleen)
Blood glucose increased
Drug ineffective
Frustration (a form of poorly expressed anger)

What are the common drug interactions of Gaviscon and Sennosides, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Febrile neutropenia (fever with reduced white blood cells)
C-reactive protein increased
Cachexia (loss of weight)
Chronic kidney disease
Haemoglobin decreased
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Platelet count decreased
Pleural effusion (water on the lungs)
Renal failure (kidney dysfunction)

60+:

Nausea (feeling of having an urge to vomit)
Blood glucose increased
Atrial tachycardia (rhythm disturbance that arises in the atria)
Back pain
Blindness
Cardiospasm (heart spasm)
Carotid artery occlusion (artery blockage)
Chest pain
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Dehydration (dryness resulting from the removal of water)

What are the existing conditions these people have? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 20 people, 64.52%
Reflux Laryngitis (voice disorder caused by backflow of stomach fluids to the throat and voice box area): 20 people, 64.52%
Diabetes: 20 people, 64.52%
Blood Pressure Abnormal: 19 people, 61.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 19 people, 61.29%
Ill-Defined Disorder: 18 people, 58.06%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 6.45%
Pain: 2 people, 6.45%
Irritable Bowel Syndrome: 2 people, 6.45%
High Blood Cholesterol: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Gaviscon and Sennosides?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously